CyberKnife Radiosurgery for Locally Recurrent Prostate CA
The purpose of this study is to scientifically evaluate the effects (good and bad) of a new type of radiation treatment in patients with locally recurrent prostate cancer after prior radiotherapy. The treatment is known as prostate radiosurgery, and is distinguished from traditional radiotherapy by the application of smaller, more precisely controlled margins around the area targeted for full dose radiation, and far fewer treatments, using a much larger dose per treatment.
This research is being done to see what advantages, if any, prostate radiosurgery may have over other salvage treatment methods, including brachytherapy, cryosurgery, high intensity focused ultrasound (HIFU), hormonal therapy and radical prostatectomy.
|Study Design:||Intervention Model: Single Group Assignment
Masking: No masking
Primary Purpose: Treatment
|Official Title:||VIRTUAL HDR CYBERKNIFE RADIOSURGERY FOR LOCALLY RECURRENT PROSTATIC CARCINOMA: A PHASE II STUDY|
- Establish pattern of PSA decline [ Time Frame: Post CyberKnife Radiosurgery - 5 year f/up ]
- Quality of Life realitive to other commonly used radiation treatment methods for recurrent prostate cancer [ Time Frame: Post CyberKnife Radiosurgery/5 yr. f/up ]
|Study Start Date:||February 2009|
|Estimated Primary Completion Date:||February 2020 (Final data collection date for primary outcome measure)|
Single arm study using CyberKnife radiosurgery to treat recurrent prostate cancer patients that have already received external beam radiotherapy.
Radiation: CyberKnife Radiosurgery
Please refer to this study by its ClinicalTrials.gov identifier: NCT00851916
|Contact: Carlyn Tripp||619-230-0400 ext email@example.com|
|United States, California|
|CybeKnife Centers of San Diego||Recruiting|
|San Diego, California, United States, 92024|
|Principal Investigator: Donald B. Fuller, M.D.|
|Principal Investigator:||Donald B Fuller, M.D.||CyberKnife Centers of San Diego|